Johnson & Johnson Halts Varipulse Heart Device Rollout in the US Due to Stroke Risk Investigation - PRESS AI WORLD
PRESSAI
Recent Posts
side-post-image
side-post-image
Johnson & Johnson Halts Varipulse Heart Device Rollout in the US Due to Stroke Risk Investigation

Credited from: REUTERS

  • Johnson & Johnson has halted the rollout of its Varipulse heart device in the United States.
  • The pause is a precautionary measure following four reported stroke events linked to the device.
  • This device had received FDA approval in November for treating abnormal heart rhythms.
  • J&J's stock dropped by 3%, while competitors like Boston Scientific and Medtronic saw gains.
  • The investigation into the stroke reports is ongoing, and international activities remain unaffected.

For more details, visit the original article.


Gallery

SHARE THIS ARTICLE:

nav-post-picture
nav-post-picture